Alexander Philipp

机构：LMU Klinikum, Comprehensive Cancer Center Erlangen, Ludwig-Maximilians-Universität München · ORCID：0000-0002-0215-9977

发表论文 69 篇 · 总被引 1820 次 · h-index 17

代表论文

• Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy (2024 · Hepatology · 被引 37)
• Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients (2024 · Gastrointestinal Endoscopy · 被引 18)
• Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity (2025 · JHEP Reports · 被引 5)
• OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy (2024 · Journal of Hepatology · 被引 4)
• Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study (2025 · Therapeutic Advances in Medical Oncology · 被引 3)
• Sequential or up-front triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma (HCC): MONTBLANC. (2024 · Journal of Clinical Oncology · 被引 3)